Telemedicine Education for Rural Children With Asthma

This study has been completed.

Sponsor:

Arkansas Children's Hospital Research Institute

ClinicalTrials.gov Identifier:

NCT00964301

First Posted: August 24, 2009

Last Update Posted: September 12, 2017

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.

The investigators will implement an interactive school-based telemedicine education program for rural low-income, minority children with asthma, their caregivers, and school nurses in the Delta region of Arkansas.

Specific aims:

The investigators will examine changes in asthma symptoms control and other health outcomes such as activity levels and family/child emotional health in the intervention group compared to a usual care group.

The investigators will examine changes in asthma knowledge, self-efficacy, and quality of life in the intervention participants and their caregivers compared to a usual care group.

Further study details as provided by Arkansas Children's Hospital Research Institute:

Primary Outcome Measures:

The investigators will examine changes in asthma symptoms control and health outcomes in the intervention group compared to a usual care group. [ Time Frame: One year ]

Secondary Outcome Measures:

The investigators will examine changes in asthma knowledge, self-efficacy, and quality of life of the intervention participants and their caregivers compared to a usual care group. [ Time Frame: One year ]

School Nurse Asthma Education. School nurses will participate in 2 sessions.

Primary Care Provider (PCP) Communication. The PCP of the intervention group participant will be notified of his/her patient's baseline asthma assessment. They will receive updates summarizing each telemedicine intervention.

Participants will receive asthma care by their PCP with no education sessions or PCP communications by the research staff.

Detailed Description:

The investigators will conduct a prospective study to examine the impact of an interactive, telemedicine asthma intervention among children living in the rural Delta region of Arkansas.

Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:

7 Years to 17 Years (Child)

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Criteria

Inclusion Criteria:

Study participants will be English-speaking children ages 7-17 years with physician-diagnosed asthma and/or active symptoms in the previous 12 months.

Active symptoms include one or more of the following:

experience daytime wheezing, shortness of breath, and/or coughing two or more times a week for the last 4 weeks;

nighttime wheezing, shortness of breath and/or cough more than once a week;

take asthma medication more than two days a week;

have been treated in a hospital or emergency department two or more times in the last two years for asthma symptoms;

have been treated in a hospital or emergency department two or more times in the last two years for asthma symptoms have episodes of asthma-like symptoms when playing/exercising.

Potentially eligible participants will be screened using an asthma screener to confirm eligibility.

Exclusion Criteria:

Children with significant underlying respiratory disease other than asthma (such as cystic fibrosis) or significant co-morbid conditions (such as severe developmental delay or cerebral palsy) will be excluded from the study.

The primary caregiver and child will be asked questions via telephone interview about how asthma affects the child every day. Children with no telephone number or contact telephone number will be excluded.

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00964301